{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"BioBreakthroughs","title":"#8 - Sandra von Meier, Head of Business Development at Debiopharm","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/3478e20e\"></iframe>","width":"100%","height":180,"duration":975,"description":"Join us on the latest episode! Our Guest: Sandra von Meier, Head of Business Development at Debiopharm\nWhat you'll get out of this episode:\n- Sandra's background\n- Overview of Debiopharm\n- Tell us about Debiopharm’s approach to drug development. How does it work with startups to enhance innovation and expedite clinical trial timelines?\n- What steps can companies take to improve patient quality of life in drug development?\n- As the world continues to face a global drug shortage, how does Debiopharm bridge the gap between disruptive research and real-world application to ensure patients receive the life-saving drugs they need?\n- What’s next for the future of biopharma?\nTo learn more about Debiopharm: https://www.debiopharm.com/\n\nFull Episode and more info here: https://loom.ly/dkKu8RA\n\nOur sponsors for this episode are: \nSage Growth Partners https://www.sage-growth.com\nFlipMD by GoodRX https://www.goodrx.com/\nQuantum Health https://quantum-health.com/","thumbnail_url":"https://img.transistorcdn.com/roxGfgcNItysBs3fg55SsdSx4l_Pbz86Ktm2KMDYkR4/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzQwNjg1LzE2ODE5/MzQxODQtYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}